###begin article-title 0
Regulation of hypoxia-inducible factor-1alpha by NF-kappaB
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
1These authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
HIF (hypoxia-inducible factor) is the main transcription factor activated by low oxygen tensions. HIF-1alpha (and other alpha subunits) is tightly controlled mostly at the protein level, through the concerted action of a class of enzymes called PHDs (prolyl hydroxylases) 1, 2 and 3. Most of the knowledge of HIF derives from studies following hypoxic stress; however, HIF-1alpha stabilization is also found in non-hypoxic conditions through an unknown mechanism. In the present study, we demonstrate that NF-kappaB (nuclear factor kappaB) is a direct modulator of HIF-1alpha expression. The HIF-1alpha promoter is responsive to selective NF-kappaB subunits. siRNA (small interfering RNA) studies for individual NF-kappaB members revealed differential effects on HIF-1alpha mRNA levels, indicating that NF-kappaB can regulate basal HIF-1alpha expression. Finally, when endogenous NF-kappaB is induced by TNFalpha (tumour necrosis factor alpha) treatment, HIF-1alpha levels also change in an NF-kappaB-dependent manner. In conclusion, we find that NF-kappaB can regulate basal TNFalpha and, in certain circumstances, the hypoxia-induced HIF-1alpha.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 549 550 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 977 978 959 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1012 1013 994 995 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1044 1046 1026 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1127 1128 1109 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
HIF (hypoxia-inducible factor) plays key roles in development, physiological processes and pathological conditions as its presence affects survival, cell-cycle progression and metabolism [1,2]. Although first identified as the main transcription factor activated under low oxygen tensions, HIF is a key transcription factor activated by cytokines, oncogenes and ROS (reactive oxygen species) under normoxic conditions [3]. HIF is a heterodimeric factor composed of alpha and beta subunits [also called ARNT (aryl hydrocarbon nuclear translocator)] [1]. Although HIF-1beta is constitutively expressed and not regulated by oxygen levels, HIF-alpha subunits are tightly controlled at the protein level. This occurs, predominantly, through the concerted action of a class of enzymes called PHDs (prolyl hydroxylases) that catalyse prolyl hydroxylation of HIF-alpha subunits, which incessantly targets them for VHL (von Hippel-Lindau protein)-dependent 26S proteasomal degradation [4]. PHD enzymes require molecular O2, 2-oxoglutarate, iron ions (Fe2+) and ascorbic acid to be fully active, and are inhibited in hypoxic conditions [4].
###end p 5
###begin p 6
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 225 226 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 303 304 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 305 306 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
Four PHDs have been identified so far, but only three, PHDs 1, 2 and 3, have been functionally characterized in terms of HIF modulation [4]. PHD2 is thought to be the dominant PHD in controlling HIF-1alpha following hypoxia [5]. Furthermore, all three PHDs can be regulated by HIF and by oxygen levels [6-8].
###end p 6
###begin p 7
###xml 109 112 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">803</sup>
###xml 133 136 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">851</sup>
###xml 430 431 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 709 711 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 712 714 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1249 1250 1217 1218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1251 1252 1219 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1325 1327 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
In addition to the HIF-alpha stabilization mechanism controlled by prolyl hydroxylation, hydroxylation of Asn803 in HIF-1alpha or Asn851 in HIF-2alpha, prevents interaction with the CH1 domains of histone acetyltransferases {p300/CBP [CREB (cAMP-response-element-binding protein)-binding protein]} that act as transcriptional co-activators. This modification alters the ability of HIF-1/HIF-2 to transactivate their target genes [9]. Although most knowledge regarding HIF-1 has been derived from studies following hypoxic stress, HIF-1 stabilization has also been found in non-hypoxic settings, such as relatively well-oxygenated regions of tumours, and in diseases such as rheumatoid arthritis and diabetes [10,11]. However, the mechanisms for HIF stabilization under those conditions have not been elucidated. Many of the stimuli that induce HIF-1 in normoxia are known to activate a number of other transcription factors such as NF-kappaB (nuclear factor kappaB). It is therefore plausible that cross-talk between these two transcription factors can occur. In addition, the HIF-1alpha and PHD1 promoters contain NF-kappaB-binding sites, which have not been functionally characterized. Importantly, HIF-1alpha stabilization and induction through H2O2 was recently shown to be NF-kappaB dependent under normoxic conditions [12].
###end p 7
###begin p 8
###xml 491 493 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 793 795 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 796 798 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1199 1201 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
NF-kappaB is the collective name for a transcription factor that exists as either a hetero- or homo-dimer and is formed by a family of subunits called RelA (p65), RelB, cRel, p50 and its precursor p105 (NF-kappaB1), and p52 and its precursor p100 (NF-kappaB2). Some dimers are more prevalent than others and they shuttle between the cytoplasm and nucleus but are predominantly sequestered in the inactive state in the cytoplasm, inhibited by members of the IkappaB (inhibitor of NF-kappaB) [13]. Upon stimulation, by compounds such as TNFalpha (tumour necrosis factor alpha), oncogenes or UV light, a kinase signalling cascade results in phosphorylation of IkappaB, signalling ubiquitination-mediated proteasomal degradation, resulting in NF-kappaB release and translocation into the nucleus [13,14]. The activated NF-kappaB dimer then binds to target DNA sequences in the nucleus where it regulates transcription of NF-kappaB target genes. Although NF-kappaB activation is extremely fast, the cyclic nature of NF-kappaB activity, in combination with post-translational modifications and hyper- and hypo-acetylated histones at target genes are indicative of further levels of regulatory complexity [15].
###end p 8
###begin p 9
###xml 803 810 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
There have been several studies demonstrating cross-talk between the NF-kappaB and HIF signalling pathways, including shared target genes, but a direct link has yet to be elucidated. In the present study, we show that several NF-kappaB subunits are bound to the HIF-1alpha promoter. NF-kappaB depletion results in reduced basal levels of HIF-1alpha mRNA. In addition, we demonstrate that TNFalpha-induced NF-kappaB can increase HIF-1alpha mRNA, protein and activity levels, leading to transactivation of target genes in normoxia. Changes in HIF-1alpha levels following hypoxia are only seen when the NF-kappaB pathway is completely blocked. These results demonstrate that NF-kappaB can directly modulate the HIF-1alpha pathway, and that this modulation is sufficient to alter HIF target gene expression in vivo.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Tissue culture, medium and hypoxia treatments
###end title 11
###begin p 12
###xml 167 170 159 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 179 182 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 200 203 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 640 641 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 461 465 <span type="species:ncbi:9913">calf</span>
U2OS osteosarcoma and HEK (human embryonic kidney)-293 cell lines were obtained from the European Collection of Cell Cultures. IKK (IkappaB kinase) wild-type, IKKalpha-/-, IKKbeta-/- and IKKalpha/beta-/- mouse embryonic fibroblasts were a gift from Professor Inder Verma (Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, U.S.A.). All cells were grown in DMEM (Dulbecco's modified Eagle medium; Lonza) supplemented with 10% fetal calf serum (Gibco), 50 units/ml penicillin (BioWhittaker) and 50 mug/ml streptomycin (BioWhittaker) for no more than 30 passages. For hypoxia treatments, cells were placed in 1% O2 using an InVivo 300 workstation (Ruskin).
###end p 12
###begin title 13
siRNA (small interfering RNA) transfection and sequences
###end title 13
###begin p 14
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 537 539 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
siRNA duplex oligonucleotides were synthesized by MWG and transfected using Interferin (Polyplus) following the manufacturer's protocol. The oligonucleotides used were: Control, 5'-AACAGUCGCGUUUGCGACUGG-3' [16]; RelA, 5'-GCUGAUGUGCACCGACAAG-3' [16]; RelB, 5'-AAUUGGAGAUCAUCGACGAGU-3'; p50/p105, 5'-AAGGGGCUAUAAUCCUGGACU-3'; p52/p100, 5'-AAGAUGAAGAUUGAGCGGCCU-3' [17]; HIF-1alpha, 5'-CUGAUGACCAGCAACUUGA-3'; IKKalpha, 5'-GCAGGCUCUUUCAGGGACA-3'; and IKKbeta, 5'-CAGGUGAGCAGAUUGCCAU-3'. The cRel siRNA sequence was as described previously [17].
###end p 14
###begin title 15
DNA constructs
###end title 15
###begin p 16
Individual NF-kappaB subunit expression vectors were a gift from Professor Neil Perkins (Division of Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, Scotland, U.K.). HIF-1alpha promoter luciferase constructs were a gift from Dr Carine Michiels (Department of Biology, University of Namur, Namur, Belgium).
###end p 16
###begin title 17
Antibodies
###end title 17
###begin p 18
###xml 488 489 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
Antibodies against HIF-1alpha, (R&D Systems), RelA (p65), RelB, cRel, p50 (NF-kappaB1), Chk1 (checkpoint kinase 1) and p52 (NF-kappaB2) were from Santa Cruz Biotechnology. Antibodies against GLUT (glucose transporter) 1/3 were from Neomarkers, against HIF-2alpha were from Novus Biologicals, against HIF-1beta, IKKalpha and IKKbeta were from Cell Signalling, against beta-actin and PCNA (proliferating-cell nuclear antigen) were from Sigma, against PHD2 were from Abcam, and against Bcl-XL were from Merck Biosciences. Enhanced chemiluminescence (Pierce) was used for detection.
###end p 18
###begin title 19
qRT-PCR (quantitative reverse transcriptase PCR)
###end title 19
###begin p 20
qRT-PCR was carried out in a 25 mul total reaction mixture with 1 mul of extracted RNA sample (10 pg-100 ng), 12.5 mul of One-Step RT (reverse transcriptase) qPCR master mix Plus for SYBR Green I (Eurogentec), 0.2 muM forward primer, 0.2 muM reverse primer, 0.125 units/ml EuroScript RT and 10.875 mul of RNase-free distilled water. Amplification and detection were performed using a Rotor-Gene 3000 (Corbett Research) and IQ5 Icycler (Bio-Rad) detection system under the following conditions: an initial reverse transcription at 48 degreesC for 30 min, followed by PCR activation at 95 degreesC for 10 min and 45 cycles of amplification (15 s at 95 degreesC and 1 min at 58 degreesC). During amplification, a detector monitored real-time PCR amplification by quantitative analysis of the fluorescence emissions. Sample values obtained with specific primer sets were normalized to beta-actin primer set values.
###end p 20
###begin title 21
qRT-PCR primer sequences
###end title 21
###begin p 22
For qRT-PCR, the following primer sequences were used: beta-actin forward, 5'-GTGGGAGTGGGTGGAGGC-3' and reverse, 5'-TCAACTGGTCTCAAGTCAGTG-3'; 18S forward, 5'-AAACGGCTACCACATCCAAG-3' and reverse, 5'-CGCTCCCAAGATCCAACTAC-3'; GLUT1 forward, 5'-GATTGGCTCCTTCTCTGTGG-3' and reverse, 5'-TCAAAGGACTTGCCCAGTTT-3'; GLUT3 forward, 5'-CAATGCTCCTGAGAAGATCATAA-3' and reverse, 5'-AAAGCGGTTGACGAAGAGT-3'; HIF-1alpha forward, 5'-CATAAAGTCTGCAACATGGAAGGT-3' and reverse, 5'-ATTTGATGGGTGAGGAATGGGTT-3'; and HIF-2alpha forward, 5'-GCGCTAGACTCCGAGAACAT-3' and reverse, 5'-TGGCCACTTACTACCTGACCCTT-3'.
###end p 22
###begin title 23
ChIP (chromatin immunoprecipitation)
###end title 23
###begin p 24
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 267 268 267 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
Proteins were cross-linked with formaldehyde for 10 min. After adding 0.125 mol/l glycine, cell lysis buffer [1% SDS, 10 mM EDTA, 50 mM Tris/HCl (pH 8.1), 1 mM PMSF, 1 mg/ml leupeptin and 1 mg/ml aprotonin] was added, followed by sonication and centrifugation (13000 g for 10 min at 4 degreesC). The supernatant was precleared with sheared salmon sperm DNA and Protein A-Sepharose beads (Sigma). The supernatant was incubated with specific antibodies overnight, and then with Protein A-Sepharose beads for 1 h. After an extensive wash step, the complexes were eluted with buffer (100 mmol/l sodium bicarbonate and 1% SDS) and incubated with proteinase K. DNA was purified using the QIAquick PCR purification kit (Qiagen). PCR was performed with primers for the HIF-1alpha promoter (forward, 5'-GAACAGAGAGCCCAGCAGAG-3' and reverse, 5'-CCTGAGGTGGAGGCGGGTTC-3') flanking the NF-kappaB-binding site (-197/188 bp) at 64 degreesC annealing and 72 degreesC extension for 32 cycles. This primer set spans from -536 to -137 bp from the transcription start site. The HIF-1alpha control primer set was 5'-TGCTCATCAGTTGCCACTTC- 3' (forward) and 5'-AAAACATTGCGACCACCTTC-3' (reverse). This primer set is located in the gene itself, 24937 bp away from the transcription start site. The primers used for HIF-1alpha target genes promoters were: VEGF (vascular-endothelial growth factor) forward, 5'-ACGTTCCTTAGTGCTGGCGGGTAGGTTTGA-3' and reverse, 5'-GCACCAAGTTTGTGGAGCTGAGAACGGG-3'; CA9 forward, 5'-GACAAACCTGTGAGACTTTGGCTCC-3' and reverse, 5'-AGTGACAGCAGCAGTTGCACAGTG-3'; and DEC1 forward, 5'-CACGTGAGACTCATGTGATGAAGCC-3' and reverse, 5'-AAGCCGAGGAGTAATGGAGAGGCT-3'.
###end p 24
###begin title 25
Other experimental procedures
###end title 25
###begin p 26
###xml 154 157 154 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17a">17a</xref>
Luciferase assays, whole cell protein, nuclear extracts and EMSA (electrophoretic mobility-shift assay) analysis were performed as described previously ([17a] and references therein). RNA was extracted using a nucleospin RNA II kit (Machery-Nagel). The EMSA probe used for HIF-1alpha kappaB site was 5'-GCGTGGGCTGGGGTGGGGACTTGCCGCCTGCGTCGC-3'.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
Differential control of the HIF-1alpha promoter by NF-kappaB subunits
###end title 28
###begin p 29
###xml 55 57 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 99 101 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 213 215 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 283 285 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 435 443 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 553 555 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 637 646 605 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 652 653 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 943 951 891 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1181 1189 1117 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1371 1379 1307 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1483 1491 1415 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1420 1423 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The HIF-1alpha promoter was originally cloned in 1996 [18] and a study by Michiels and co-workers [19], identified several binding sites for transcription factors such as AP-1 (activator protein 1) and NF-kappaB [19]. Given the advance in our knowledge of NF-kappaB consensus sites [14], we reanalysed the HIF-1alpha promoter (). This analysis identified a putative NF-kappaB-binding site located -197/188 bp from the initiation site (Figure 1a). Using HIF-1alpha promoter reporter constructs either with or without the putative NF-kappaB-binding site [19], we investigated the contribution of individual NF-kappaB subunits in normoxia (Figures 1a and 1b). All NF-kappaB subunits could activate the HIF-1alpha promoter, with the highest effect being observed with p50 and the lowest effect with p52. In contrast, none of the NF-kappaB subunits activated a truncated version of the HIF-1alpha promoter construct which lacks the NF-kappaB site (Figure 1b). To investigate whether NF-kappaB could bind the putative site on the HIF-1alpha promoter, we performed EMSAs using nuclear extracts derived from HEK-293 cells which had been transfected with the individual NF-kappaB subunits (Figure 1c). We could detect intense binding by p50, and weaker binding by p65, c-Rel and p52. No visible binding could be observed with RelB, although the expression levels were comparable (Figure 1e). Binding to the canonical site in the HIV promoter was used to assess the NF-kappaB binding ability (Figure 1d). These results suggest that NF-kappaB is able to regulate HIF-1alpha promoter activity.
###end p 29
###begin title 30
NF-kappaB subunits can activate the HIF-1alpha promoter
###end title 30
###begin p 31
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 73 74 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 365 366 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 422 423 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 708 709 673 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 749 750 714 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 846 847 807 808 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 840 843 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(a) Schematic diagram of the HIF-1alpha promoter-luciferase constructs. (b) HEK-293 cells were co-transfected with 1 mug of HIF-1alpha promoter-luciferase constructs and 1 mug of each of the NF-kappaB subunits. Luciferase activity was measured 48 h post-transfection. Values are means+S.D. for a minimum of three independent experiments performed in duplicate. The y-axis shows the fold activation above control plasmid. (c) NF-kappaB subunits bind to the kappaB site in the HIF-1alpha promoter. HEK-293 cells were transfected with 2 mug of each of the NF-kappaB subunits, nuclear extracts were prepared, and the DNA-binding activity was measured by EMSA using a specific probe for the HIF-1alpha promoter. (d) Nuclear extracts were prepared as in (c), and the DNA-binding activity was measured using a canonical NF-kappaB target promoter, HIV. (e) Nuclear extracts were analysed by Western blot for the individual NF-kappaB subunits.
###end p 31
###begin title 32
NF-kappaB modulates basal HIF-1alpha mRNA levels
###end title 32
###begin p 33
###xml 220 222 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 223 225 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 324 332 304 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 736 738 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 739 741 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 824 832 792 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 958 966 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1235 1243 1179 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
To investigate whether endogenous NF-kappaB could modulate the HIF-1alpha promoter, siRNA oligonucleotides directed towards the different NF-kappaB subunits were used. The siRNA sequences have been previously validated [16,17]. qRT-PCR analysis demonstrated that endogenous NF-kappaB regulated basal HIF-1alpha mRNA levels (Figure 2a). Interestingly, reduction of p50 levels had no effect on HIF-1alpha mRNA levels, possibly indicating a compensatory action by p52 or other NF-kappaB subunits. The co-operation between p50 and p52 is best depicted in the genetic knockout mice, where p50 and p52 single deletions showed no developmental defects, whereas double deletion of these genes resulted in severe impairment in bone development [20,21]. Endogenous p65, RelB and p52 have the highest effect on HIF-1alpha mRNA levels (Figure 2a). Despite inducing a slight reduction in HIF-1alpha mRNA, c-Rel depletion did not induce statistically significant effects (Figure 2a). To assess whether NF-kappaB is directly regulating HIF-1alpha mRNA levels, ChIP analysis was performed. Several of the NF-kappaB subunits could be found at the HIF-1alpha promoter; however, we could not detect any NF-kappaB binding in a control region of the gene (Figure 2b). This demonstrates that NF-kappaB modulates the basal level of HIF-1alpha mRNA directly.
###end p 33
###begin title 34
Endogenous NF-kappaB subunits control basal HIF-1alpha mRNA levels
###end title 34
###begin p 35
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 290 291 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 316 317 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 330 331 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 377 378 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 397 398 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 412 413 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 428 429 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 442 443 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 456 457 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 477 478 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 487 488 479 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
(a) HEK-293 cells were transfected with the indicated siRNA oligonucleotides, and qRT-PCR was performed. The histogram depicts the relative levels of HIF-1alpha mRNA normalized to actin mRNA levels. The mean+S.D. were calculated from a minimum of three independent experiments. A Student's t test was performed and *P<0.050 and **P<0.010 when compared with the control. Actual P values are: RelA, P=0.012; RelB, P=0.012; c-Rel, P=0.076; p50, P=0.348; p52, P=0.035; HIF-1alpha, P=0.007. (b) ChIP analysis using the indicated antibodies and PCR analysis using specific primers for the HIF-1alpha promoter and HIF-1alpha control region was performed.
###end p 35
###begin title 36
NF-kappaB modulates HIF-1alpha protein levels in normoxia
###end title 36
###begin p 37
###xml 78 80 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 569 577 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 762 770 734 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 999 1007 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1121 1129 1082 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
HIF-1alpha is predominantly regulated at the protein level following hypoxia [22]. Since the studies in the present paper were conducted at normal oxygen levels, PHD activity is not readily inhibited. To investigate whether NF-kappaB could also modulate HIF-1alpha protein levels NF-kappaB overexpression and siRNA-mediated knockdowns were used. Given that HIF-1alpha protein is rapidly degraded at normal oxygen levels, only small changes could be expected. It was possible to observe increases in protein levels when all of the NF-kappaB subunits were overexpressed (Figure 3a). However, RelA and c-Rel induced the highest increase followed by p50, p52 and RelB. Changes in HIF-1alpha protein were best visualized when the proteasome inhibitor MG132 was used (Figure 3a). Conversely, a small reduction of HIF-1alpha protein levels could be observed when RelA, RelB and p52 were depleted. A small effect was also evident when c-Rel was depleted but no effects could be detected with p50 depletion (Figure 3b). In either overexpression or siRNA-mediated knockdown of NF-kappaB subunits, HIF-1beta levels remained stable (Figure 3).
###end p 37
###begin title 38
NF-kappaB subunits control basal levels of HIF-1alpha protein
###end title 38
###begin p 39
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 298 299 297 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
(a) HEK-293 cells were transfected with the indicated DNA constructs, and whole cell lysates were obtained 48 h post-transfection. At 3 h prior to harvest, half of the samples were incubated with 50 muM MG132. Western blot analysis for the indicated proteins was then performed on these extracts. (b) HEK-293 cells were transfected with the indicated siRNA oligonucleotides, and whole cell lysates were obtained 48 h post-transfection. At 3 h prior to harvest, half of the samples were incubated with 50 muM MG132. Western blot analysis for the indicated proteins was then performed on these extracts.
###end p 39
###begin title 40
TNFalpha-induced NF-kappaB modulates HIF-1alpha expression
###end title 40
###begin p 41
###xml 72 74 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 328 330 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 331 333 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 507 515 487 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 597 605 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 729 737 697 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 849 857 813 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1193 1201 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1541 1549 1465 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
Activation of NF-kappaB is best associated with inflammatory responses [13]. It is rapidly activated following cytokines such as TNFalpha or bacterial products such as LPS (lipopolysaccharide). In fact, these stimuli have both been described to activate HIF-1alpha as well, although the mechanism has not been fully elucidated [23,24]. Given that prolonged TNFalpha exposure is present in many inflammatory diseases and certain cancers, we investigated whether HIF-1alpha was induced under such conditions (Figure 4). We exposed cells to TNFalpha for several hours and analysed nuclear fractions (Figure 4a). It was possible to detect nuclear accumulation of all NF-kappaB subunits and also a significant increase in HIF-1alpha (Figure 4a). Furthermore, this prolonged TNFalpha treatment also induced increases in two HIF target genes: GLUT1 and 3 (Figure 4b). To test whether the observed increases in HIF-1alpha, GLUT1 and GLUT3 protein resulted from higher mRNA levels, qRT-PCR was performed for the indicated times following TNFalpha treatment. Interestingly, it was possible to observe an increase in HIF-1alpha, GLUT3 and to a lesser extent GLUT1 mRNA with no change in HIF-2alpha mRNA (Figure 4c). These results indicate that the HIF-1alpha and GLUT3 protein increases resulted from increased gene transcription, whereas the increase in HIF-2alpha levels was possibly due to protein stability effects. Furthermore, siRNA-mediated depletion of HIF-1alpha or HIF-2alpha demonstrated that TNFalpha-induced GLUT3 is HIF-1alpha-dependent (Figure 4d and Supplementary Figure S1 at ), indicating that TNFalpha-induced HIF-1alpha is active transcriptionally.
###end p 41
###begin title 42
TNFalpha treatment induces NF-kappaB and HIF-1alpha
###end title 42
###begin p 43
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 225 226 221 222 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 254 255 250 251 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 345 346 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 374 375 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 643 644 635 636 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 813 814 801 802 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
(a) HEK-293 cells were treated with 10 ng/ml TNFalpha for the indicated times, nuclear extracts were prepared, and these extracts were analysed by Western blot for the indicated proteins. PCNA was used as a loading control. (b) Cells were treated as in (a), and cell extracts were analysed by Western blot for the indicated HIF-1alpha targets. (c) Cells were treated as in (a), but mRNA was extracted and qRT-PCR was performed for the indicated gene transcripts. The histogram depicts relative levels of specific mRNA transcripts normalized to actin mRNA levels. The mean+S.D. were calculated from a minimum of three independent experiments. (d) Cells were transfected with the indicated siRNA oligonucleotides and treated with 10 ng/ml TNFalpha, 24 h prior to total mRNA extraction. qRT-PCR was performed as in (c).
###end p 43
###begin title 44
TNFalpha-induced HIF-1alpha activity is NF-kappaB dependent
###end title 44
###begin p 45
###xml 285 293 261 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 583 591 543 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
To test whether the observed changes in HIF-1alpha were NF-kappaB dependent, siRNA for the different NF-kappaBs was combined with TNFalpha treatment. Depletion of all of the subunits, with the exception of p105/p50, resulted in an impairment of TNFalpha-induced HIF-1alpha expression (Figure 5a). In addition, depletion of HIF-1alpha resulted in impaired TNFalpha induction of PHD2 (Supplementary Figure S2 at ), indicating that this is a HIF-1alpha-dependent event. Furthermore, an inducible recruitment of HIF-1alpha to the promoters of some of its target genes was also detected (Figure 5b).
###end p 45
###begin title 46
TNFalpha induces HIF-1alpha activity in an NF-kappaB-dependent manner
###end title 46
###begin p 47
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 242 243 238 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 350 354 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 356 359 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CA9</italic>
###xml 364 368 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEC1</italic>
###xml 402 403 394 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 412 413 404 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 479 480 467 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 508 509 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
(a) HEK-293 cells were transfected with the indicated siRNA oligonucleotides, treated with 10 ng/ml TNFalpha 24 h prior to harvest, and whole cell lysates were prepared. Extracts were analysed by Western blot using the indicated antibodies. (b) ChIP analysis using the indicated antibodies and PCR of specific regions of the HIF-1alpha target genes, VEGF, CA9 and DEC1. HRE, hypoxia-response element. (c) As in (b) but the HIF-1alpha promoter and control regions were analysed. (d) Cells were treated as in (a), and Western blot analysis was performed using the indicated antibodies. PCNA was used as a loading control.
###end p 47
###begin p 48
###xml 227 235 211 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 461 469 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
To verify that TNFalpha was inducing changes at the HIF-1alpha promoter, ChIPs were performed. It was possible to observe, following 18 h of TNFalpha treatment, an active recruitment of RelA and p52 to the HIF-1alpha promoter (Figure 5c). Importantly, TNFalpha treatment did not induce NF-kappaB binding to a control region of the HIF-1alpha gene. Furthermore, depletion of RelA, RelB, c-Rel and p52 reduced TNFalpha-induced HIF-1alpha-mediated PHD2 induction (Figure 5d). These results indicate that TNFalpha-induced changes in HIF-1alpha levels and activity are NF-kappaB-dependent.
###end p 48
###begin title 49
Complete block of the NF-kappaB activation pathway prevents hypoxia-induced HIF-1alpha
###end title 49
###begin p 50
###xml 435 444 408 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 450 451 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 692 700 658 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1138 1146 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1248 1256 1182 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
Given that NF-kappaB can control basal HIF-1alpha mRNA levels, we investigated whether blocking NF-kappaB could prevent hypoxia-induced HIF-1. We took advantage of genetic knockout cells and also used siRNA for the upstream kinase complex that regulates NF-kappaB. We could observe that, when IKKalpha or IKKbeta were depleted, either by genetic knockout or siRNA-mediated silencing, there was very little effect on HIF-1alpha levels (Figures 6a and 6b), suggesting that protein stabilization can compensate for any impairment in the canonical or non-canonical pathways. However, when both IKKalpha and IKKbeta were depleted, HIF-1 stabilization in response to hypoxia was severely impaired (Figure 6c). This suggests that HIF-1alpha gene transcription is mediated by several subunits of NF-kappaB and these derive from both pathways of activation. These results support our mRNA and ChIP results on how NF-kappaB controls the HIF pathway. Given that hypoxia does not induce increases in HIF-1alpha mRNA, it was not surprising that no changes in NF-kappaB recruitment to the HIF-1alpha promoter were observed following hypoxia treatment (Figure 6d). Once again, we could not detect any NF-kappaB binding to a control region of the HIF-1alpha gene (Figure 6d). These results suggest that any impairment seen in HIF-1alpha stabilization following hypoxia, in the absence of NF-kappaB, is due to changes in basal mRNA levels and not due to a lack of an active induction of mRNA.
###end p 50
###begin title 51
Complete inhibition of NF-kappaB impairs hypoxia induced HIF-1alpha levels
###end title 51
###begin p 52
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 103 104 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 198 199 191 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 220 223 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 235 238 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 287 288 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 403 404 389 390 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 433 436 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 485 486 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 601 602 580 581 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 663 664 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
(a) U2OS cells were transfected with the IKKalpha or IKKbeta siRNA oligonucleotides and exposed to 1% O2 for the indicated times prior to harvest. Whole cell lysates were analysed by Western blot. (b) Wild-type, IKKalpha-/- and IKKbeta-/- mouse embryonic fibroblasts were exposed to 1% O2 for the indicated periods of time, and whole cell lysates were prepared. Extracts were analysed by Western blot. (c) Wild-type and IKKalpha/beta-/- mouse embryonic fibroblasts were exposed to 1% O2 for the indicated periods of time, and whole cell lysates were prepared. Extracts were analysed by Western blot. (d) U2OS cells were left untreated or treated for 4 h with 1% O2 prior to harvest, and ChIP analysis using the indicated antibodies was performed. PCR analysis using specific primers for the HIF-1alpha promoter and HIF-1alpha control region was performed.
###end p 52
###begin title 53
DISCUSSION
###end title 53
###begin p 54
###xml 304 311 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 604 615 592 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1&#8211;3</xref>
###xml 617 618 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 623 624 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 822 833 798 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4&#8211;6</xref>
Chronic inflammation is self-perpetuating and has been shown to distort the microenvironment as a result of aberrantly active transcription factors. Consequent alterations in growth factor, chemokine, cytokine and ROS balance within the cellular milieu provide the axis of growth and survival needed for de novo development of cancer and metastasis [25]. As such, we hypothesized that novel interactions between two key transcription factors, NF-kappaB and HIF, existed in this process. In the present study, we demonstrate that HIF-1alpha basal mRNA levels are controlled by several NF-kappaB subunits (Figures 1-3, 5 and 6). In addition, we show that TNFalpha-, and to some extent hypoxia-, induced NF-kappaB regulates HIF-1alpha levels and activity, triggering the transcription of target genes such as GLUT3 and PHD2 (Figures 4-6).
###end p 54
###begin p 55
###xml 440 442 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 443 445 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 571 573 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 664 666 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 682 685 648 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
The results of the present study have numerous implications for a number of pathologies where NF-kappaB and HIF-1 are deregulated, such as rheumatoid arthritis or cancer. However, despite these implications, NF-kappaB regulation of HIF-1alpha could be stimulus-specific or even cell-type-specific. The evidence for this comes from the available genetic knockout models. While HIF-1alpha deletion results in embryonic lethality at day 9-11 [26,27], with defects evident as early as 7 days, combined genetic deletion of IKKalpha and IKKbeta results in lethality at day 12 [28]. Single deletions of IKKalpha, IKKbeta or RelA result in lethality at much later stages [28]. In HIF-1alpha-/- mice, defects are seen in neural tube formation, cardiovascular malformations and increases in cell death in the cephalic mesemchyme. Of interest, IKKalpha/beta double null mice also have defects in neurulation, but these seem to be associated with increased apoptosis in the neuronal epithelium. It would be interesting to re-analyse these mice embryos for HIF-1alpha expression in the different tissues.
###end p 55
###begin p 56
###xml 154 156 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 209 211 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 212 214 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
The results of the present study also demonstrate that TNFalpha induces HIF-1 activity despite the presence of oxygen. TNFalpha can produce ROS in cells [29] and these have been shown to inhibit PHD activity [30,31]. Although we have not investigated this possibility, the present results on HIF-1alpha stabilization and activity would support this. Precise ROS measurements and PHD activity assays would answer these questions.
###end p 56
###begin title 57
Online data
###end title 57
###begin title 58
Supplementary Figures S1-S2
###end title 58
###begin p 59
###xml 164 171 <span type="species:ncbi:32101">Bracken</span>
###xml 780 786 <span type="species:ncbi:9606">people</span>
We thank Professor Neil Perkins (Division of Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, Scotland, U.K.) and Dr Cameron Bracken (School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia) for helpful discussion and reagents. We are also grateful to Dr Margaret Ashcroft (Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, London, U.K.), Dr Carine Michiels (Department of Biology, University of Namur, Namur, Belgium) and Professor Inder Verma (Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, U.S.A.) for valuable reagents. We are particularly grateful to Dr Cari Culver and Sharon Mudie for help with the manuscript preparation and all of the people in the Wellcome Trust Centre for Gene Regulation and Expression and the College of Life Sciences at the University of Dundee for support. This research was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) studentship (to P.v.U.), a Royal Society research grant, a Tenovus Scotland small grant, Association for International Cancer Research (to N. K.), Research Councils UK (to S. R.) and a MRC NIRG (Medical Research Council New Investigator Research Grant). The University of Dundee is a Scottish Registered Charity (No. SC015096).
###end p 59
###begin article-title 60
Negative and positive regulation of HIF-1: a complex network
###end article-title 60
###begin article-title 61
###xml 62 67 <span type="species:ncbi:9606">human</span>
HIFing the brakes: therapeutic opportunities for treatment of human malignancies
###end article-title 61
###begin article-title 62
Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators
###end article-title 62
###begin article-title 63
Regulating cellular oxygen sensing by hydroxylation
###end article-title 63
###begin article-title 64
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia
###end article-title 64
###begin article-title 65
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phd2</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">egln</italic>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element
###end article-title 65
###begin article-title 66
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">egln3</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phd3</italic>
Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene
###end article-title 66
###begin article-title 67
###xml 74 79 <span type="species:ncbi:9606">human</span>
Hypoxia-dependent regulation of PHD1: cloning and characterization of the human PHD1/EGLN2 gene promoter
###end article-title 67
###begin article-title 68
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
###end article-title 68
###begin article-title 69
Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function
###end article-title 69
###begin article-title 70
Hypoxia and angiogenesis in rheumatoid arthritis
###end article-title 70
###begin article-title 71
Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site
###end article-title 71
###begin article-title 72
Shared principles in NF-kappaB signaling
###end article-title 72
###begin article-title 73
Good cop, bad cop: the different faces of NF-kappaB
###end article-title 73
###begin article-title 74
Post-translational modifications regulating the activity and function of the nuclear factor kappaB pathway
###end article-title 74
###begin article-title 75
Regulation of RelA (p65) function by the large subunit of replication factor C
###end article-title 75
###begin article-title 76
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit
###end article-title 76
###begin article-title 77
Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
###end article-title 77
###begin article-title 78
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation
###end article-title 78
###begin article-title 79
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR
###end article-title 79
###begin article-title 80
Requirement for NF-kappaB in osteoclast and B-cell development
###end article-title 80
###begin article-title 81
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2
###end article-title 81
###begin article-title 82
Gene regulation under low oxygen: holding your breath for transcription
###end article-title 82
###begin article-title 83
Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappaB activation
###end article-title 83
###begin article-title 84
###xml 57 62 <span type="species:ncbi:9606">human</span>
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB
###end article-title 84
###begin article-title 85
Inflammation and cancer: an ancient link with novel potentials
###end article-title 85
###begin article-title 86
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1alpha
###end article-title 86
###begin article-title 87
HIF-1alpha is required for solid tumor formation and embryonic vascularization
###end article-title 87
###begin article-title 88
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation
###end article-title 88
###begin article-title 89
###xml 94 99 <span type="species:ncbi:9606">human</span>
Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis
###end article-title 89
###begin article-title 90
Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species
###end article-title 90
###begin article-title 91
Mitochondria and cellular oxygen sensing in the HIF pathway
###end article-title 91

